Molecular Partners AG (MOLN)
3.87
+0.16
(+4.31%)
USD |
NASDAQ |
May 16, 16:00
Molecular Partners Market Cap: 127.15M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 127.15M |
| May 15, 2024 | 121.89M |
| May 14, 2024 | 116.56M |
| May 13, 2024 | 124.85M |
| May 10, 2024 | 124.85M |
| May 09, 2024 | 121.60M |
| May 08, 2024 | 123.53M |
| May 07, 2024 | 119.92M |
| May 06, 2024 | 118.60M |
| May 03, 2024 | 130.76M |
| May 02, 2024 | 123.70M |
| May 01, 2024 | 127.15M |
| April 30, 2024 | 124.22M |
| April 29, 2024 | 121.56M |
| April 26, 2024 | 127.47M |
| April 25, 2024 | 127.47M |
| April 24, 2024 | 127.47M |
| April 23, 2024 | 127.47M |
| April 22, 2024 | 127.47M |
| April 19, 2024 | 109.08M |
| April 18, 2024 | 122.88M |
| April 17, 2024 | 128.46M |
| April 16, 2024 | 128.46M |
| April 15, 2024 | 129.77M |
| April 12, 2024 | 129.77M |
| Date | Value |
|---|---|
| April 11, 2024 | 126.82M |
| April 10, 2024 | 133.39M |
| April 09, 2024 | 130.10M |
| April 08, 2024 | 130.10M |
| April 05, 2024 | 129.77M |
| April 04, 2024 | 128.46M |
| April 03, 2024 | 132.98M |
| April 02, 2024 | 128.13M |
| April 01, 2024 | 137.99M |
| March 28, 2024 | 137.99M |
| March 27, 2024 | 137.99M |
| March 26, 2024 | 139.30M |
| March 25, 2024 | 137.33M |
| March 22, 2024 | 133.55M |
| March 21, 2024 | 127.47M |
| March 20, 2024 | 127.47M |
| March 19, 2024 | 127.15M |
| March 18, 2024 | 137.51M |
| March 15, 2024 | 130.10M |
| March 14, 2024 | 126.98M |
| March 13, 2024 | 122.55M |
| March 12, 2024 | 131.24M |
| March 11, 2024 | 135.20M |
| March 08, 2024 | 137.00M |
| March 07, 2024 | 139.30M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
109.08M
Minimum
Apr 19 2024
1.030B
Maximum
Jan 14 2022
326.42M
Average
219.43M
Median
May 08 2023
Market Cap Benchmarks
| AC Immune SA | 317.47M |
| CRISPR Therapeutics AG | 4.772B |
| Addex Therapeutics Ltd | 9.384M |
| NLS Pharmaceutics Ltd | 6.641M |
| MoonLake Immunotherapeutics | 2.499B |
Market Cap Related Metrics
| PS Ratio | 16.27 |
| Price to Book Value | 0.6053 |
| Price | 3.87 |
| Earnings Yield | -54.38% |